Penumbra

Penumbra, Inc., founded in 2004, operates within the Medical Devices & Equipment and Manufacturing sectors, specializing in the design, development, manufacturing, and marketing of innovative medical devices. Globally, Penumbra serves markets across the United States, Europe, Canada, Australia, and Japan, among other international regions, positioning itself as a key innovator in healthcare through novel technologies.

With 15 locations worldwide, Penumbra's operations are extensive. Its headquarters are located in Alameda, California. Learn about Penumbra's global headquarters for detailed geographic information. The company's product suite includes advanced neurovascular access systems like the Neuron and Neuron MAX lines, crucial for neurovascular therapies. They also provide aspiration-based thrombectomy systems (Penumbra System) and revascularization devices (3D brand). Penumbra employs between 1,000 - 5,000 employees, underscoring its significant operational scale. Meet Penumbra's team to understand the expertise driving its innovation.

Penumbra reports $1.5B in revenue, competing against firms such as LivaNova, Terumo BCT, and Merit Medical. Its financial performance fuels ongoing research and development in specialized medical device fields. Explore financial highlights for detailed insights into the company's economic standing and growth trajectory. The company is publicly traded under the ticker NYSE: PEN.